Pages that link to "Q37873720"
Jump to navigation
Jump to search
The following pages link to Pathogenesis of antiphospholipid syndrome: understanding the antibodies (Q37873720):
Displaying 50 items.
- Vascular disease in systemic lupus erythematosus (Q21285155) (← links)
- Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay (Q26739950) (← links)
- Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications (Q26998188) (← links)
- Catastrophic antiphospholipid syndrome: a clinical review (Q27009935) (← links)
- Novel Phospholipid-Protein Conjugates Allow Improved Detection of Antibodies in Patients with Autoimmune Diseases (Q28552664) (← links)
- Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis (Q28740531) (← links)
- Diagnosis and management of catastrophic antiphospholipid syndrome (Q30235356) (← links)
- Antiphospholipid antibodies in iraqi women with recurrent mid-trimester abortions (Q33406095) (← links)
- Current treatment of antiphospholipid syndrome: lights and shadows (Q33423959) (← links)
- Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events (Q33431396) (← links)
- Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome (Q33435408) (← links)
- The role of platelets in antiphospholipid syndrome (Q33439904) (← links)
- Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome (Q33604935) (← links)
- Recurrent pregnancy loss: current perspectives (Q33713930) (← links)
- Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers (Q33766670) (← links)
- Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. (Q33948737) (← links)
- Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome (Q34287356) (← links)
- Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management. (Q34476952) (← links)
- Presence of autoantibody against two placental proteins, peroxiredoxin 3 and peroxiredoxin 4, in sera of recurrent pregnancy loss patients (Q34494348) (← links)
- Activated protein C resistance and antiphospholipid antibodies in recurrent fetal loss: experience of a single referral center in northern iraq (Q34569019) (← links)
- A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus (Q34722499) (← links)
- A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast. (Q34769721) (← links)
- Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice (Q35070716) (← links)
- Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I. (Q35124252) (← links)
- An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome (Q35152055) (← links)
- Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. (Q35419865) (← links)
- Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches (Q35621012) (← links)
- Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. (Q35854768) (← links)
- LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers (Q35907083) (← links)
- The complement system at the embryo implantation site: friend or foe? (Q35927443) (← links)
- Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis (Q36087118) (← links)
- Progesterone and autoimmune disease (Q36202227) (← links)
- Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome (Q36299310) (← links)
- Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome (Q36472439) (← links)
- ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice (Q36619367) (← links)
- Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome (Q36774243) (← links)
- Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy (Q36879113) (← links)
- Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers. (Q36923241) (← links)
- Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus (Q36981341) (← links)
- Detection of multiple annexin autoantibodies in a patient with recurrent miscarriages, fulminant stroke and seronegative antiphospholipid syndrome (Q37011051) (← links)
- Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells (Q37059648) (← links)
- Immunogenetic contributions to recurrent pregnancy loss (Q37059982) (← links)
- Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study (Q37228076) (← links)
- Prevalence of anti- beta2GPI antibodies and their isotypes in patients with renal diseases and clinical suspicion of antiphospholipid syndrome (Q37476122) (← links)
- Improving outcomes in patients with lupus and end-stage renal disease (Q37522782) (← links)
- Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications (Q37699576) (← links)
- Optimization of unnicked β2-glycoprotein I and high avidity anti-β2-glycoprotein I antibodies isolation (Q37704570) (← links)
- Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome (Q37704874) (← links)
- Obstetric and vascular APS: same autoantibodies but different diseases? (Q38013583) (← links)
- New Insights into the Molecular Basis of the Antiphospholipid Syndrome (Q38024789) (← links)